Clinical Trial Update: The Effect of NSAID Steroid Therapy for PGE2 Level and Analgesia After Percutaneous Nephrolithotomy Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating NSAID and corticosteroid therapy to reduce PGE2 levels and improve analgesia after percutaneous nephrolithotomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Drugs mentioned

• Corticosteroid (corticosteroid)
• Non-steroidal anti-inflammatory drug (NSAID) (NSAID)

Snippet

Sponsor: Universitas Jenderal Soedirman | Conditions: Percutaneous Nephrolithotomy (PCNL), Postoperative Pain | Phase 4 | Status: COMPLETED